ES8607950A1 - Procedimiento para preparar 6-aril-3 2h piridazinonas - Google Patents
Procedimiento para preparar 6-aril-3 2h piridazinonasInfo
- Publication number
- ES8607950A1 ES8607950A1 ES542979A ES542979A ES8607950A1 ES 8607950 A1 ES8607950 A1 ES 8607950A1 ES 542979 A ES542979 A ES 542979A ES 542979 A ES542979 A ES 542979A ES 8607950 A1 ES8607950 A1 ES 8607950A1
- Authority
- ES
- Spain
- Prior art keywords
- pyridazinones
- preparation
- medicaments containing
- alkoxy
- denotes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE 6-ARIL-32HPIRAZINONAS Y DE SUS SALES CON BASES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE UNO DE LOS RADICALES R1 Y R2 REPRESENTA HIDROGENO O ALCOXI C1-4, Y EL OTRO REPRESENTA POLIFLUORO-ALCOXI C1-4. CONSISTE EN LA REACCION DE HIDRAZINA CON UN ACIDO ACRILICO DE FORMULA (II), EN LA QUE R1 Y R2 TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, EN MEDIO NEUTRO O LIGERAMENTE ACIDO CON UNA CANTIDAD MOLAR EQUIVALENTE A UN EXCESO DEL 50% DE HIDRAZINA, A LA TEMPERATURA AMBIENTE O LIGERAMENTE SUPERIOR. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD BRONCOESPASMOLITICA Y CARDIOTONICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH229784 | 1984-05-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES542979A0 ES542979A0 (es) | 1986-06-16 |
ES8607950A1 true ES8607950A1 (es) | 1986-06-16 |
Family
ID=4230485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES542979A Expired ES8607950A1 (es) | 1984-05-10 | 1985-05-09 | Procedimiento para preparar 6-aril-3 2h piridazinonas |
Country Status (15)
Country | Link |
---|---|
US (1) | US4665074A (es) |
EP (1) | EP0163965B1 (es) |
JP (1) | JPH062750B2 (es) |
AT (1) | ATE47844T1 (es) |
AU (1) | AU578947B2 (es) |
CA (1) | CA1245651A (es) |
DE (1) | DE3574137D1 (es) |
DK (1) | DK159431C (es) |
ES (1) | ES8607950A1 (es) |
GR (1) | GR851039B (es) |
IE (1) | IE58033B1 (es) |
IL (1) | IL75070A (es) |
NZ (1) | NZ211995A (es) |
PT (1) | PT80426B (es) |
ZA (1) | ZA853504B (es) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0469013B1 (de) * | 1989-04-17 | 1995-06-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel |
US5376656A (en) * | 1990-10-16 | 1994-12-27 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Arylpyridazinones |
AU1574892A (en) * | 1991-04-26 | 1992-12-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel pyridazines |
ATE141791T1 (de) | 1991-07-05 | 1996-09-15 | Byk Gulden Lomberg Chem Fab | Verwendung substituierter pyridazine gegen dermatosen |
PT706513E (pt) * | 1993-07-02 | 2002-10-31 | Byk Gulden Lomberg Chem Fab | Benzimidazois substituidos por fluoralcoxi e sua utilizacao como inibidores de fosfodiesterase nucleotidica ciclica |
US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
AU8106598A (en) | 1997-06-03 | 1998-12-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
US7378400B2 (en) * | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
US7427606B2 (en) * | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
SI1212089T1 (sl) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Sinergisticna kombinacija roflumilasta in salmeterola |
US20040146561A1 (en) | 2001-05-23 | 2004-07-29 | Naoki Sakurai | Compositions for promoting healing of bone fracture |
EP1389467B1 (en) | 2001-05-23 | 2013-07-03 | Mitsubishi Tanabe Pharma Corporation | Therapeutic composition for the regenerative treatment of cartilage diseases |
AU2002362443B2 (en) * | 2001-10-01 | 2008-05-15 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
JP2006522151A (ja) | 2003-04-01 | 2006-09-28 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 不妊症におけるホスホジエステラーゼ阻害剤 |
US7407965B2 (en) * | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
US20050261237A1 (en) * | 2003-04-25 | 2005-11-24 | Boojamra Constantine G | Nucleoside phosphonate analogs |
US7432261B2 (en) * | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
KR20060022647A (ko) * | 2003-04-25 | 2006-03-10 | 길리애드 사이언시즈, 인코포레이티드 | 키나아제 억제 포스포네이트 유사체 |
US20090247488A1 (en) * | 2003-04-25 | 2009-10-01 | Carina Cannizzaro | Anti-inflammatory phosphonate compounds |
WO2004096286A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Antiviral phosphonate analogs |
US7470724B2 (en) * | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
US7452901B2 (en) * | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
US7432273B2 (en) * | 2003-10-24 | 2008-10-07 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
ES2363160T3 (es) | 2004-07-27 | 2011-07-22 | Gilead Sciences, Inc. | Conjugados de fosfonato nucelosidico como agentes anti-vih. |
WO2006028618A1 (en) * | 2004-08-02 | 2006-03-16 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
WO2006023272A1 (en) * | 2004-08-02 | 2006-03-02 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having a2a agonist activity |
US7605143B2 (en) * | 2004-08-02 | 2009-10-20 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity |
WO2007120972A2 (en) * | 2006-02-10 | 2007-10-25 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
US8188063B2 (en) * | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US8058259B2 (en) * | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
AU2009268681B2 (en) | 2008-07-08 | 2014-10-02 | Gilead Sciences, Inc. | Salts of HIV inhibitor compounds |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
EA201391254A1 (ru) | 2011-03-01 | 2014-02-28 | Синерджи Фармасьютикалз Инк. | Способ получения агонистов гуанилатциклазы c |
EP2958577A2 (en) | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylate cyclase receptor agonists for use in colonic cleansing |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
PT3004138T (pt) | 2013-06-05 | 2024-06-18 | Bausch Health Ireland Ltd | Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos |
AU2014305843B2 (en) | 2013-08-09 | 2019-08-29 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
FR3027901B1 (fr) * | 2014-10-31 | 2018-03-16 | Universite De Reims Champagne Ardenne | Nouveaux procedes appartenant a la famille des pyridazinones. |
WO2019027920A1 (en) | 2017-08-01 | 2019-02-07 | Gilead Sciences, Inc. | CRYSTALLINE FORMS OF ETHYL ((S) - (((((2R, 5R) -5- (6-AMINO-9H-PURIN-9-YL) -4-FLUORO-2,5-DIHYDROFURAN-2-YL) OXY ) METHYL) (PHENOXY) PHOSPHORYL) -L-ALANINATE (GS-9131) FOR THE TREATMENT OF VIRAL INFECTIONS |
WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2435244A1 (de) * | 1974-07-22 | 1976-02-05 | Lentia Gmbh | Verfahren zur herstellung von 3-phenylpyridazonen |
DE2445681A1 (de) * | 1974-09-25 | 1976-04-15 | Lentia Gmbh | Verfahren zur herstellung von 3-phenylpyridazonen |
JPS6037101B2 (ja) * | 1977-03-09 | 1985-08-24 | 三共株式会社 | フエニルピリダジノン誘導体の製法 |
DE2757923A1 (de) * | 1977-12-24 | 1979-06-28 | Hoechst Ag | Verfahren zur herstellung von 3-pyridazonen |
US4397854A (en) * | 1981-05-14 | 1983-08-09 | Warner-Lambert Company | Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
ES532337A0 (es) * | 1983-05-11 | 1985-12-01 | Byk Gulden Lomberg Chem Fab | Procedimiento para la preparacion de 6-aril-3 (2h)piridazinonas |
IT1173591B (it) * | 1983-05-11 | 1987-06-24 | Byk Gulden Lomberg Chem Fab | Piridazioni,loro preparazione e impiego,farmaci contenenti piridazioni |
-
1985
- 1985-04-19 DK DK177585A patent/DK159431C/da not_active IP Right Cessation
- 1985-04-29 AU AU41775/85A patent/AU578947B2/en not_active Ceased
- 1985-04-29 GR GR851039A patent/GR851039B/el unknown
- 1985-05-02 IL IL75070A patent/IL75070A/xx unknown
- 1985-05-06 NZ NZ211995A patent/NZ211995A/en unknown
- 1985-05-07 EP EP85105535A patent/EP0163965B1/de not_active Expired
- 1985-05-07 US US06/731,580 patent/US4665074A/en not_active Expired - Fee Related
- 1985-05-07 DE DE8585105535T patent/DE3574137D1/de not_active Expired
- 1985-05-07 AT AT85105535T patent/ATE47844T1/de not_active IP Right Cessation
- 1985-05-09 PT PT80426A patent/PT80426B/pt not_active IP Right Cessation
- 1985-05-09 ES ES542979A patent/ES8607950A1/es not_active Expired
- 1985-05-09 IE IE114685A patent/IE58033B1/en not_active IP Right Cessation
- 1985-05-09 CA CA000481149A patent/CA1245651A/en not_active Expired
- 1985-05-09 ZA ZA853504A patent/ZA853504B/xx unknown
- 1985-05-10 JP JP60098184A patent/JPH062750B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US4665074A (en) | 1987-05-12 |
NZ211995A (en) | 1987-11-27 |
DK159431C (da) | 1991-03-18 |
IE58033B1 (en) | 1993-06-16 |
ES542979A0 (es) | 1986-06-16 |
AU4177585A (en) | 1985-11-14 |
IL75070A0 (en) | 1985-09-29 |
PT80426A (de) | 1985-06-01 |
IE851146L (en) | 1985-11-10 |
CA1245651A (en) | 1988-11-29 |
IL75070A (en) | 1988-11-15 |
DE3574137D1 (en) | 1989-12-14 |
EP0163965A3 (en) | 1987-06-24 |
PT80426B (de) | 1987-04-16 |
DK159431B (da) | 1990-10-15 |
ZA853504B (en) | 1985-12-24 |
AU578947B2 (en) | 1988-11-10 |
JPH062750B2 (ja) | 1994-01-12 |
EP0163965A2 (de) | 1985-12-11 |
ATE47844T1 (de) | 1989-11-15 |
GR851039B (es) | 1985-05-28 |
DK177585A (da) | 1985-11-11 |
JPS60246375A (ja) | 1985-12-06 |
EP0163965B1 (de) | 1989-11-08 |
DK177585D0 (da) | 1985-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8607950A1 (es) | Procedimiento para preparar 6-aril-3 2h piridazinonas | |
ES8607252A1 (es) | Procedimiento para preparar derivados de imidazol | |
ES8405766A1 (es) | Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol | |
ES482134A1 (es) | Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido. | |
ES8702371A1 (es) | Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona. | |
ES2004386A6 (es) | Un procedimiento para producir un nuevo derivado de difluorohalometoxifenilo | |
AU560607B2 (en) | Pyridazinones their preparation and use and medicaments containing pyridazinones | |
ES8605538A1 (es) | Procedimiento para la preparacion de nonapeptidos y dodecapeptidos | |
ES8400752A1 (es) | "procedimiento para la preparacion de nuevos derivados de ciclofosfamida". | |
ES8301221A1 (es) | Un procedimiento para la preparacion de derivados de imida- zol | |
ES8705421A1 (es) | Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas | |
ES8604520A1 (es) | Procedimiento para preparar derivados de 2(1h)-piridona | |
ES8801633A1 (es) | Procedimiento para preparar nuevos derivados de 3-piridil-metilnaftilo | |
DE3374005D1 (en) | 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle | |
ES464150A1 (es) | Procedimiento para la preparacion de compuestos derivados defenil-amino-2-imidazolina | |
GB1262267A (en) | Substituted 2-amino-3-imino-3,5-dihydrophenazines | |
ES8500619A1 (es) | Procedimiento de preparacion de derivados de eburnano-oxima racemicos u opticamente activos. | |
ES8606272A1 (es) | Procedimiento para preparar derivados carboxialquildipepti- dicos | |
ES8103047A1 (es) | Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios | |
ES8106156A1 (es) | Un procedimiento para la preparacion de derivados de oxadia-zolotriazona | |
CA2012661A1 (en) | Thienylpiperazines, process for the Preparation Thereof, the Use Thereof, and Pharmaceuticals Containing These and the Preparation Thereof | |
ES8706653A1 (es) | Un procedimiento para la preparacion depropionilamilidas | |
MY102050A (en) | Imidazole anologs of mevalonolactone and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970612 |